Clearance Summary
AccuFFRangio Plus received FDA 510(k) clearance under submission number K230303, sponsored by ArteryFlow Technology Co., Ltd.. The device was reviewed via the Special premarket notification pathway and assigned to the Radiology review panel. The statutory decision date of record is 2023-03-02.
- Submission: K230303
- Applicant / Sponsor: ArteryFlow Technology Co., Ltd.
- Clearance pathway: Special
- Review panel: Radiology
- Device class: Class II
- Regulation citation: 21 CFR 892.1600
- Decision date: 2023-03-02
Classification & Regulation
This clearance is catalogued under FDA product code QHA and 21 CFR 892.1600, within the Radiology review panel as a Class II device.